JBS
JBS N.V.
NYSE · Consumer Defensive · Packaged Foods · NL
$13.01
−1.03%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 382.2B | 471.1B | 417.0B | 363.8B | 384.0B |
| Cost of Revenue | 336.9B | 410.8B | 354.2B | 324.2B | 322.9B |
| Gross Profit | 45.3B | 60.3B | 62.8B | 39.6B | 61.0B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 30.3B | 37.8B | 37.0B | 34.0B | 34.9B |
| General & Admin Expense | 3.8B | — | 10.9B | 11.0B | 11.8B |
| Selling & Marketing Expense | 7.2B | — | 26.1B | 22.9B | 23.1B |
| Other Expenses | 293.1M | (78.5M) | 2.0B | 368.7M | 798.3M |
| Total Operating Expenses | 30.6B | 37.7B | 39.0B | 34.3B | 35.7B |
| Cost and Expenses | 367.5B | 448.5B | 393.2B | 358.5B | 358.7B |
| Operating Income (EBIT) | 14.7B | 22.6B | 23.8B | 5.3B | 25.3B |
| Non-Operating | |||||
| Interest Income | 907.4M | 2.3B | 453.7M | 326.4M | 268.4M |
| Interest Expense | 5.9B | 9.2B | 1.6B | 1.7B | 1.3B |
| Net Interest Income | (5.0B) | (6.9B) | (1.2B) | (1.4B) | (1.1B) |
| Other Non-Op Income/Expense | (6.9B) | (8.2B) | (8.9B) | (6.7B) | (6.5B) |
| Non-Operating Income (excl Interest) | (1.1B) | (955.8M) | (1.9B) | (657.6M) | (595.3M) |
| EBT (Pre-Tax Income) | 7.8B | 14.4B | 14.8B | (1.4B) | 18.8B |
| Income Tax Expense | 801.5M | 2.2B | 4.1B | (668.9M) | 2.2B |
| Bottom Line | |||||
| Net Income | 6.4B | 11.1B | 9.6B | (1.1B) | 15.9B |
| Earnings from Cont. Ops | 7.0B | 12.2B | 10.7B | (729.1M) | 16.6B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 6.4B | 11.1B | 9.6B | (1.1B) | 15.9B |
| Per Share | |||||
| Basic EPS | $3.75 | $10.41 | $0.80 | ($0.48) | $7.09 |
| Diluted EPS | $6.19 | $10.41 | $0.80 | ($0.48) | $7.09 |
| Revenue Per Share | $374.30 | $440.93 | $187.98 | $164.02 | $170.32 |
| Shares | |||||
| Basic Shares Outstanding | 1.0B | 1.1B | 2.2B | 2.2B | 2.3B |
| Diluted Shares Outstanding | 1.0B | 1.1B | 2.2B | 2.2B | 2.3B |
| Profitability Metrics | |||||
| EBITDA | 27.0B | 36.2B | 35.4B | 14.7B | 36.0B |
| D&A | 11.2B | 12.6B | 9.7B | 8.8B | 10.1B |
| EBIT | 15.8B | 23.6B | 25.7B | 6.0B | 25.9B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026